MAPT and Alzheimer disease: The observed changes in the inhibitory neurotransmitter system, exemplified by γ-aminobutyric acid,212 and the potential for excitotoxicity to alter cognitive levels earlier than Aβ and tau pathologies,209 suggest that excitotoxicity might hold greater potential in AD treatment.